MedPath

Efficacy and Mechanisms of Acupuncture for Patients With Advanced Pancreatic Cancer Pain

Phase 3
Conditions
Pain
Pancreatic Cancer
Interventions
Device: Acupuncture
Device: Placebo acupuncture
Registration Number
NCT02510066
Lead Sponsor
Shanghai Cancer Hospital, China
Brief Summary

This study compares the effect of acupuncture and placebo acupuncture on advanced pancreatic cancer pain and then investigates its potential mechanism of peripheral blood.

Detailed Description

Acupuncture may alleviate abdominal or back pain of patients with advanced pancreatic cancer. Acupuncture participants would receive electroacupuncture on Jiaji (Ex-B2) points for 3 times in a week. Placebo acupuncture participants would receive placebo acupuncture on non-point points for the same period. Pain scores on numeric rating scale (NRS) and blood levels of β-endorphin and nerve growth factor are compared.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Advanced pancreatic cancer at Ⅲ-Ⅳ stage diagnosed by histological/cytological examination.
  • Pain score of abdominal or back pain ≥3 on a numeric rating scale (NRS) graduated from 0 to 10.
  • Stable dose of analgesics at least 72 hours before randomization.
  • Expected survival time more than 1 month.
Exclusion Criteria
  • Another cause for abdominal or back pain (such as prolapse of lumbar intervertebral disc, ulcer or other intra-abdominal disorder).
  • Acupuncture treatment in the past.
  • Contraindications for the use of acupuncture (such as severe allergies, bleeding tendency, infectious dermatosis and ulcer or scar at points).
  • Unable to give informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AcupunctureAcupunctureAcupuncture participants would receive electroacupuncture on Jiaji (Ex-B2) points for 3 times in a week.
Placebo acupuncturePlacebo acupuncturePlacebo acupuncture participants would receive placebo acupuncture on non-point points for the same period.
Primary Outcome Measures
NameTimeMethod
Pain scores, assessed with numeric rating scale (NRS)1 week
Secondary Outcome Measures
NameTimeMethod
Blood levels of β-endorphin1 week
Karnofsky performance status (KPS) score1 week
Blood levels of nerve growth factor1 week

Trial Locations

Locations (1)

Shanghai Cancer Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath